ARTL Message Board Post 9904012 | Artelo Biosciences Inc.
home / stock / artl / artl message board
wgreg41
(investorshub)
Posted on: Feb/23/2021 12:15:47
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=162055244
$ARTL pre-market gap filled at 1.60...1,8. weak market
News, Short Squeeze, Breakout and More Instantly...
-
ART26.12 seeks to address a critical need in painful neuropathies, including chemotherapy-induced peripheral neuropathy for which there is no FDA-approved treatment Phase 1 trial results expected in the first half of 2025 SOLANA BEACH, Calif., July 15, 2024 (GLOBE NEWSWIRE) -- A...
-
SOLANA BEACH, Calif., July 03, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic and neurological condit...
-
Inhibition of FABP5 Demonstrates Activity in Cancer, Psoriasis, and Anxiety Disorders Results from Several Research Studies Presented at the Annual ICRS Symposium SOLANA BEACH, Calif., July 02, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a c...